Identify optimal HAP series scores for unresectable HCC patients undergoing TACE plus sorafenib: A Chinese multicenter observational study

Overview of attention for article published in Frontiers in oncology, January 2023

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 3 Mendeley

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 24,271 followers.

Identify optimal HAP series scores for unresectable HCC patients undergoing TACE plus sorafenib: A Chinese multicenter observational study https://t.co/KWycEWy3Bp https://t.co/DbOCixgRD4

28 Jan 2023

Reply Repost Favourite

New research: Identify optimal HAP series scores for unresectable HCC patients undergoing TACE plus sorafenib: A Chinese multicenter observational study: Background Hepatoma arterial-embolization prognostic (HAP) series scores have been… https://t.co/ASDg

28 Jan 2023

Reply Repost Favourite

#4 Original Research Article: Identify optimal HAP series scores for unresectable HCC patients undergoing TACE plus sorafenib: A Chinese multicenter observational study 👨‍⚕️👩‍⚕️ Zhu Y et al Available here #OpenAccess 👉 https://t.co/TQPy9WRsXT #Hepatocel

27 Jan 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.